K. Kuroiwa

发表

Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer.

M. Kattan, H. Hricak, P. Scardino, 2005, The Journal of urology.

Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.

Oliver Sartor, John Trachtenberg, Michel Rossignol, 2007, The Journal of urology.

Assessment of biologic aggressiveness of prostate cancer: correlation of MR signal intensity with Gleason grade after radical prostatectomy.

H. Hricak, K. Kuroiwa, Y. Mazaheri, 2008, Radiology.

Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.

M. Kattan, H. Hricak, P. Scardino, 2006, Radiology.

The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis

M. Kattan, H. Hricak, P. Scardino, 2007, BJU international.

Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer.

B. Guillonneau, A. Vickers, K. Kuroiwa, 2007, European urology.

Gleason score correlation between biopsy and prostatectomy specimens and prediction of high-grade Gleason patterns: significance of central pathologic review.

K. Kuroiwa, S. Naito, T. Shiraishi, 2011, Urology.

Twist1 and Y-box-binding protein-1 are potential prognostic factors in bladder cancer.

K. Kuroiwa, Y. Oda, T. Uchiumi, 2014, Urologic oncology.

Renal cell carcinoma with rhabdoid features: an aggressive neoplasm

K. Kuroiwa, Y. Oda, H. Shiratsuchi, 2002, Histopathology.

Mutual Regulation between Raf/MEK/ERK Signaling and Y-Box–Binding Protein-1 Promotes Prostate Cancer Progression

K. Kuroiwa, Y. Oda, M. Shiota, 2013, Clinical Cancer Research.

Human Cancer Biology Mutual Regulation between Raf / MEK / ERK Signaling and Y-Box – Binding Protein-1 Promotes Prostate Cancer Progression

K. Kuroiwa, Y. Oda, M. Shiota, 2013 .

Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer

N. Kinukawa, K. Kuroiwa, O. Ogawa, 2008, The Journal of urology.

Poorly differentiated prostate cancer treated with radical prostatectomy: long-term outcome and incidence of pathological downgrading.

P. Scardino, J. Eastham, A. Vickers, 2006, The Journal of urology.

Human heterochromatin protein 1 isoform HP1beta enhances androgen receptor activity and is implicated in prostate cancer growth.

K. Kuroiwa, N. Seki, Y. Oda, 2010, Endocrine-related cancer.

Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab

K. Kuroiwa, N. Seki, T. Tomoda, 2022, Cancer management and research.

Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study.

K. Kuroiwa, N. Seki, T. Tomoda, 2022, Clinical genitourinary cancer.

External Validation of a Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Patients Receiving Post-Docetaxel Second-Line Chemotherapy

K. Kuroiwa, M. Shiota, A. Yokomizo, 2022, JMA journal.

P300/CBP‐associated factor regulates Y‐box binding protein‐1 expression and promotes cancer cell growth, cancer invasion and drug resistance

Ken Yamamoto, K. Kuroiwa, T. Uchiumi, 2010, Cancer science.

Antioxidant therapy alleviates oxidative stress by androgen deprivation and prevents conversion from androgen dependent to castration resistant prostate cancer.

K. Kuroiwa, Y. Oda, T. Uchiumi, 2012, The Journal of urology.

Optimal Timing of Sequencing From Platinum-based Chemotherapy to Pembrolizumab for Advanced Urothelial Carcinoma Based on Real-World Data: A Multi-Institutional Retrospective Study

K. Kuroiwa, T. Tomoda, Yoshifumi Hori, 2020 .

Predictive factors of late biochemical recurrence after radical prostatectomy

K. Kuroiwa, T. Tomoda, Yoshifumi Hori, 2017, Japanese journal of clinical oncology.

Fat detection in granular-cell renal cell carcinoma using chemical-shift gradient-echo MR imaging: another renal tumor that contains fat

H. Honda, K. Kuroiwa, S. Naito, 2011, Abdominal Imaging.

Efficacy and safety of cabazitaxel therapy in elderly (≥75 years) patients with castration-resistant prostate cancer: A multiinstitutional study

K. Kuroiwa, M. Shiota, A. Yokomizo, 2020, Prostate international.

Prognostic significance of lactate dehydrogenase in cabazitaxel chemotherapy for castration-resistant prostate cancer: a multi-institutional study

K. Kuroiwa, M. Shiota, A. Yokomizo, 2020, Anti-cancer drugs.

Therapeutic Outcome of >10 Cycles of Cabazitaxel for Castration-resistant Prostate Cancer: A Multi-institutional Study

K. Kuroiwa, M. Shiota, A. Yokomizo, 2019, Anticancer Research.

Efficacy and safety of 4-weekly cabazitaxel for castration-resistant prostate cancer: a multi-institutional study

K. Kuroiwa, M. Shiota, A. Yokomizo, 2019, Cancer Chemotherapy and Pharmacology.

Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel

K. Kuroiwa, M. Shiota, A. Yokomizo, 2020, AntiCancer Research.

Efficacy and safety of cabazitaxel for castration-resistant prostate cancer in patients with > 10 cycles of docetaxel chemotherapy: a multi-institutional study

K. Kuroiwa, M. Shiota, A. Yokomizo, 2019, Medical Oncology.

Binding Protein-1 Promotes Prostate Cancer Progression − Mutual Regulation between Raf/MEK/ERK Signaling and Y-Box

K. Kuroiwa, Y. Oda, M. Shiota, 2013 .

Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells

K. Kuroiwa, M. Shiota, A. Yokomizo, 2011, The Prostate.

Causes of diminished renal function in the affected kidney after partial nephrectomy

K. Kuroiwa, A. Yokomizo, J. Inokuchi, 2012, BJU international.

Impact of cold and warm ischemia on postoperative recovery of affected renal function after partial nephrectomy.

K. Kuroiwa, A. Yokomizo, A. Takeuchi, 2011, Journal of endourology.

Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomy.

B. Guillonneau, P. Scardino, J. Eastham, 2007, European urology.

RISK-ADJUSTED ANALYSIS OF POSITIVE SURGICAL MARGINS FOLLOWING LAPAROSCOPIC AND RETROPUBIC RADICAL PROSTATECTOMY

B. Guillonneau, P. Scardino, J. Eastham, 2006 .

Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.

K. Kuroiwa, Y. Oda, T. Uchiumi, 2011, Endocrine-related cancer.

Dissociated response among multiple metastatic lesions in the patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.

K. Kuroiwa, E. Okajima, N. Nishiyama, 2022, Japanese journal of clinical oncology.

Optimal Timing of Switching from Platinum-based Chemotherapy to Pembrolizumab for Advanced Urothelial Carcinoma Based on Real-world Data: A Multi-institutional Retrospective Study

K. Kuroiwa, T. Tomoda, Yoshifumi Hori, 2022, AntiCancer Research.

The clinical features of anterior prostate cancers

P. Scardino, J. Eastham, V. Reuter, 2006, BJU international.

Positive surgical margins and accessory pudendal artery preservation during laparoscopic radical prostatectomy.

B. Guillonneau, A. Vickers, K. Kuroiwa, 2005, European urology.

Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppression

K. Kuroiwa, M. Shiota, A. Yokomizo, 2011, Cancer Chemotherapy and Pharmacology.

Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis.

H. Hricak, P. Scardino, O. Akin, 2006, Radiology.

Effectiveness and safety of radium‐223 dichloride in patients with castration‐resistant prostate cancer and bone metastases in real‐world practice: A multi‐institutional study

K. Kuroiwa, M. Shiota, A. Yokomizo, 2022, International journal of urology : official journal of the Japanese Urological Association.

The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status

K. Kuroiwa, N. Seki, T. Tomoda, 2022, OncoTargets and therapy.

OTT_A_389138 1321..1330

K. Kuroiwa, N. Seki, T. Tomoda, 2022 .

Impact of a multidisciplinary continuous quality improvement program on the positive surgical margin rate after laparoscopic radical prostatectomy.

B. Guillonneau, P. Scardino, V. Reuter, 2006, European urology.

Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging.

Evis Sala, Chaya S Moskowitz, Oguz Akin, 2006, Radiology.

Is intraoperative frozen section analysis an efficient way to reduce positive surgical margins?

Toshiki Tsuboi, Michael W Kattan, Victor E Reuter, 2005, Urology.

Ectonucleoside triphosphate diphosphohydrolase 6 expression in testis and testicular cancer and its implication in cisplatin resistance.

K. Kuroiwa, Y. Oda, M. Shiota, 2011, Oncology reports.

The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer

K. Kuroiwa, Y. Oda, M. Shiota, 2011, Modern Pathology.

The significance of strong histone deacetylase 1 expression in the progression of prostate cancer

K. Kuroiwa, M. Tsuneyoshi, S. Tamiya, 2011, Histopathology.

Foxo3a Suppression of Urothelial Cancer Invasiveness through Twist1, Y-Box–Binding Protein 1, and E-Cadherin Regulation

K. Kuroiwa, Y. Oda, T. Uchiumi, 2010, Clinical Cancer Research.

Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate‐specific antigen relapse time after radical prostatectomy

K. Kuroiwa, Y. Oda, T. Uchiumi, 2011, Cancer science.

Sorafenib with doxorubicin augments cytotoxicity to renal cell cancer through PERK inhibition.

K. Kuroiwa, T. Uchiumi, M. Shiota, 2010, International journal of oncology.

p300 mediates cellular resistance to doxorubicin in bladder cancer.

K. Kuroiwa, M. Shiota, A. Yokomizo, 2011, Molecular medicine reports.

Prognostic significance of location of positive margins in radical prostatectomy specimens.

P. Scardino, J. Eastham, V. Reuter, 2007, Urology.

MDR1 gene overexpression and altered degree of methylation at the promoter region in bladder cancer during chemotherapeutic treatment.

K. Kuroiwa, M. Kuwano, S. Naito, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Advances in Brief MDR 1 Gene Overexpression and Altered Degree of Methylation at the Promoter Region in Bladder Cancer during Chemotherapeutic Treatment 1

K. Kuroiwa, M. Kuwano, S. Naito, 2000 .

Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin

K. Kuroiwa, T. Uchiumi, M. Shiota, 2010, Cancer science.

Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.

K. Kuroiwa, T. Uchiumi, M. Shiota, 2010, Molecular endocrinology.

Sunitinib enhances antitumor effects against chemotherapy-resistant bladder cancer through suppression of ERK1/2 phosphorylation.

K. Kuroiwa, M. Shiota, M. Itsumi, 2012, International journal of oncology.

Impact of reporting rules of biopsy Gleason score for prostate cancer

K. Kuroiwa, S. Naito, H. Uchino, 2008, Journal of Clinical Pathology.

Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab

K. Kuroiwa, N. Seki, T. Tomoda, 2022 .

Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancer

H. Nishiyama, K. Kuroiwa, M. Shiota, 2021, Cancer science.

Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.

H. Hricak, P. Scardino, J. Eastham, 2007, International journal of radiation oncology, biology, physics.

Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram.

Michael W Kattan, Hedvig Hricak, Liang Wang, 2007, Radiology.

The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab

K. Kuroiwa, N. Seki, T. Tomoda, 2021, Cancer management and research.

Site-specific Response to Nivolumab in Renal Cell Carcinoma

K. Kuroiwa, E. Okajima, N. Nishiyama, 2021, AntiCancer Research.

Clinical Outcomes of Mixed Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy

K. Kuroiwa, N. Seki, T. Tomoda, 2021, In Vivo.

Treating Japanese Patients With Pembrolizumab for Platinum-Refractory Advanced Urothelial Carcinoma in Real-World Clinical Practice

K. Kuroiwa, T. Tomoda, Yoshifumi Hori, 2020, Journal of clinical medicine research.

YB-1 suppression induces STAT3 proteolysis and sensitizes renal cancer to interferon-α

K. Kuroiwa, M. Shiota, M. Itsumi, 2013, Cancer Immunology, Immunotherapy.

N-myc downstream regulated gene-1/Cap43 may play an important role in malignant progression of prostate cancer, in its close association with E-cadherin.

K. Kuroiwa, Y. Oda, M. Kuwano, 2010, Human pathology.

Cell proliferative activity and expression of cell‐cell adhesion factors (E‐cadherin, α‐, β‐, and γ‐catenin, and p120) in sarcomatoid renal cell carcinoma

K. Kuroiwa, M. Tsuneyoshi, T. Konomoto, 2001 .

Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy

K. Kuroiwa, N. Seki, T. Tomoda, 2021, OncoTargets and therapy.

Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A

K. Kuroiwa, O. Ogawa, J. Inokuchi, 2017, World Journal of Urology.

1574: Is Focal Therapy Reasonable in Patients with Early Stage Prostate Cancer (CAP) - an Analysis of Radical Prostatectomy (RP) Specimens

P. Scardino, J. Eastham, K. Kuroiwa, 2006 .

Epithelial to Mesenchymal Transition in Clear Cell Renal Cell Carcinoma with Rhabdoid Features

K. Kuroiwa, Y. Oda, M. Shiota, 2016, Pathobiology (Basel).

Renal cell carcinoma with rhabdoid-like features lack intracytoplasmic inclusion bodies and show aggressive behavior

K. Kuroiwa, Y. Oda, M. Shiota, 2016, Virchows Archiv.

Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer.

H. Nishiyama, K. Kuroiwa, S. Fukushima, 2010, Journal of endourology.

MR detection of cytoplasmic fat in clear cell renal cell carcinoma utilizing chemical shift gradient‐echo imaging

H. Honda, K. Kuroiwa, S. Naito, 1999, Journal of magnetic resonance imaging : JMRI.

Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.

K. Kuroiwa, M. Yasuda, M. Fujisawa, 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

The second nationwide surveillance of the antimicrobial susceptibility of Neisseria gonorrhoeae from male urethritis in Japan, 2012-2013.

K. Kuroiwa, M. Yasuda, M. Fujisawa, 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Efficacy of combined androgen blockade therapy in patients with metastatic hormone‐sensitive prostate cancer stratified by tumor burden

H. Nishiyama, K. Kuroiwa, M. Shiota, 2022, International journal of urology : official journal of the Japanese Urological Association.

Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients

H. Nishiyama, K. Kuroiwa, M. Shiota, 2020, Cancer science.

Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience.

Jason A Koutcher, Chaya S Moskowitz, Amita Shukla-Dave, 2005, Radiology.

Discrepancy between local and central pathological review of radical prostatectomy specimens.

Taizo Shiraishi, Seiji Naito, Yoshihiko Hirao, 2009, The Journal of urology.

Androgen receptor signaling regulates cell growth and vulnerability to doxorubicin in bladder cancer.

K. Kuroiwa, M. Shiota, A. Yokomizo, 2012, The Journal of urology.

Paclitaxel and carboplatin chemotherapy after platinum-based chemotherapy and pembrolizumab for metastatic urothelial carcinoma

K. Kuroiwa, T. Tomoda, Yoshifumi Hori, 2021, Molecular and clinical oncology.

A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.

K. Kuroiwa, M. Tsuneyoshi, S. Naito, 2004, The Journal of urology.

Transurethral endoscopic treatment of patients with upper tract urothelial carcinomas using neodymium‐YAG and/or holmium‐YAG laser ablation

K. Kuroiwa, A. Yokomizo, K. Tatsugami, 2010, BJU international.

Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.

H. Nishiyama, K. Kuroiwa, O. Ogawa, 2019, The Journal of urology.

Depth and origin of prostatic involvement by urothelial carcinoma: prognostic significance and staging interpretation.

K. Kuroiwa, A. Yokomizo, S. Naito, 2011, Japanese journal of clinical oncology.

Endorectal MR imaging before salvage prostatectomy: tumor localization and staging.

Evis Sala, Chaya S Moskowitz, Oguz Akin, 2006, Radiology.

Urinary Bladder Carcinoma Surveillance Counterpoint: Japan

K. Kuroiwa, 2013 .

Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer

H. Nishiyama, K. Kuroiwa, T. Habuchi, 2020, International journal of urology : official journal of the Japanese Urological Association.

FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y‐Box Binding Protein‐1 Expression in Prostate Cancer

K. Kuroiwa, Y. Oda, M. Shiota, 2017, The Prostate.

Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?

H. Hricak, O. Akin, K. Kuroiwa, 2010, BJU international.

Quality improvement in laparoscopic radical prostatectomy for pT2 prostate cancer: impact of video documentation review on positive surgical margin.

B. Guillonneau, V. Reuter, K. Kuroiwa, 2005, The Journal of urology.

[Clinical review of 105 cases of adrenal tumor, with special reference to incidental tumor].

K. Kuroiwa, J. Kumazawa, S. Naito, 1996, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

THE ASSOCIATION OF TLX3 METHYLATION WITH RESISTANCE TO CISPLATIN IN BLADDER CANCER

C. Plass, K. Kuroiwa, A. Yokomizo, 2008 .

Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.

H. Hricak, V. Reuter, O. Akin, 2007, Radiology.

The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies.

William C Huang, Bobby Shayegan, Samson W Fine, 2007, The Journal of urology.

[Clinicopathological analysis of transition zone cancer of the prostate: the clinical significance of coexistent non-transition zone cancer foci].

K. Kuroiwa, S. Naito, Y. Hasegawa, 1999, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

Presence of ganglia within the prostatic capsule: Ganglion involvement in prostatic cancer

K. Kuroiwa, S. Naito, H. Koga, 1999, The Prostate.

Histopathologic subtype-specific genomic profiles of renal cell carcinomas identified by high-resolution whole-genome single nucleotide polymorphism array analysis.

Ken Yamamoto, K. Kuroiwa, M. Shiota, 2010, Oncology letters.